Joseph Michael Burnett is CEO & President at ClearPoint Neuro, Inc. (CLPT). They have made 7 open-market trades across 2 companies since 2018, most recently 2025-03-12.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $68K since 2018, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLPT | SELL | 2022-08-15 | 2022-08-16 | $16.07 | $606K | -16.7% | -23.0% | -34.6% |
| CLPT | SELL | 2021-11-11 | 2021-11-12 | $16.88 | $169K | -11.8% | -30.6% | -45.8% |
| CLPT | SELL | 2021-09-21 | 2021-09-21 | $17.98 | $347K | -3.4% | -0.6% | -39.0% |
| CLPT | SELL | 2021-06-21 | 2021-06-22 | $18.57 | $464K | -2.9% | -1.9% | -3.5% |
| MRIC | BUY | 2018-09-25 | 2018-09-25 | $1.25 | $31K | +5.6% | +8.3% | +8.3% |
| MRIC | BUY | 2018-08-22 | 2018-08-24 | $1.57 | $19K | +5.6% | +8.3% | +8.3% |
| MRIC | BUY | 2018-05-21 | 2018-05-23 | $2.39 | $18K | +5.6% | +8.3% | +8.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.